Virinchi Ltd

Virinchi Ltd

₹ 15.3 -2.74%
04 Jun - close price
About

Incorporated in 1991, Virinchi Ltd is an IT Products & Services company which offers customized solutions to companies globally[1]

Key Points

Business Overview:[1][2]
Virinci is a CMMi Level 3, software products and services company. It deals in Fintech and Healthcare sector with a Loan Management System for Short Term Micro Credit Industry, Full Scale IT services with competency in Analytics & Mobility and Healthcare Delivery Business in India comprising 3 Operating Hospitals with a Pan-India Healthcare Mobility solution.

  • Market Cap 169 Cr.
  • Current Price 15.3
  • High / Low 32.7 / 13.6
  • Stock P/E
  • Book Value 45.3
  • Dividend Yield 0.00 %
  • ROCE 1.31 %
  • ROE -5.39 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.34 times its book value
  • Promoter holding has increased by 2.59% over last quarter.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.24% over past five years.
  • Company has a low return on equity of -0.85% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
78 80 72 73 75 76 74 82 69 80 62 77 66
43 50 50 44 47 54 50 56 52 54 51 51 64
Operating Profit 35 30 22 29 28 22 24 27 17 26 11 26 2
OPM % 45% 37% 31% 40% 38% 29% 32% 32% 24% 33% 17% 33% 3%
1 0 0 0 4 1 0 0 6 0 0 0 1
Interest 11 11 10 11 11 10 10 9 10 9 8 8 8
Depreciation 11 15 13 14 12 13 13 16 14 14 14 14 14
Profit before tax 15 4 0 5 8 0 2 2 -1 3 -12 4 -18
Tax % 17% -13% -880% -7% 75% -518% 90% -114% 293% 87% 18% 61% -14%
12 4 1 6 2 1 0 4 -4 0 -14 2 -16
EPS in Rs 1.45 0.51 0.17 0.61 0.22 0.11 0.02 0.37 -0.43 0.04 -1.32 0.16 -1.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
139 218 287 341 406 380 353 362 311 298 301 284
117 187 223 245 286 269 257 261 204 188 211 220
Operating Profit 22 31 64 96 120 111 96 101 107 109 90 64
OPM % 16% 14% 22% 28% 30% 29% 27% 28% 34% 37% 30% 23%
2 2 2 1 4 2 6 3 4 5 7 2
Interest 2 3 12 18 22 22 33 27 34 43 40 33
Depreciation 11 12 25 33 36 44 48 48 56 54 55 56
Profit before tax 11 18 30 46 66 46 22 28 21 17 2 -23
Tax % 25% 11% 20% 28% 11% -2% 88% 50% 38% 23% 79% 19%
8 16 24 33 59 46 3 14 13 13 0 -27
EPS in Rs 2.30 4.50 4.42 5.85 9.46 7.11 0.37 1.80 1.54 1.46 0.07 -2.40
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 3%
5 Years: -4%
3 Years: -3%
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -3728%
Stock Price CAGR
10 Years: -5%
5 Years: -12%
3 Years: -25%
1 Year: -35%
Return on Equity
10 Years: 5%
5 Years: 1%
3 Years: -1%
Last Year: -5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 18 18 27 28 31 33 37 79 84 94 103 109
Reserves 89 106 180 228 287 343 339 292 324 361 373 384
31 110 158 157 162 156 261 276 317 330 292 273
12 30 53 80 55 38 50 56 62 66 79 84
Total Liabilities 150 264 418 494 535 571 687 703 787 851 847 850
75 143 316 323 376 395 495 479 460 547 569 532
CWIP 4 17 3 5 0 4 11 11 110 83 86 86
Investments 0 1 1 1 0 0 0 2 2 3 2 1
71 104 98 164 159 171 181 212 214 218 191 231
Total Assets 150 264 418 494 535 571 687 703 787 851 847 850

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
12 23 79 35 81 85 50 82 127 116 84 21
-3 -94 -126 -51 -83 -68 -154 -34 -137 -114 -78 -19
2 73 31 14 1 -17 115 -31 4 -13 -19 -1
Net Cash Flow 11 2 -16 -1 -1 -0 10 18 -6 -11 -12 1
Free Cash Flow 9 -70 -46 -15 -3 17 -104 50 -9 3 5 2
CFO/OP 67% 80% 133% 50% 73% 76% 72% 95% 127% 110% 95% 44%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 50 90 53 84 69 72 80 76 78 91 98 111
Inventory Days 131 148 195 187 161
Days Payable 305 172 130 122 94
Cash Conversion Cycle 50 90 53 84 -106 48 145 142 145 91 98 111
Working Capital Days -5 40 -7 29 32 58 56 59 72 64 63 106
ROCE % 10% 11% 14% 16% 20% 13% 10% 9% 8% 8% 5% 1%

Insights

In beta
Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Jun 2022 Mar 2024 Mar 2025
Healthcare Bed Capacity
Number

Log in to view insights

Please log in to see hidden values.

Login
vCard Cards Issued
Number
vCard Mobile App Installs
Million
SaaS Client Point of Sale Locations
Number
Total Loan Amount Sanctioned (Cumulative)
USD Billion
Total Number of Loans Sanctioned (Cumulative)
Million
Total Number of Payments Processed (Cumulative)
Million
Total Number of Unique Borrower Accounts (Cumulative)
Million

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
41.33% 40.04% 39.72% 37.30% 37.59% 38.07% 37.59% 37.51% 37.51% 37.51% 37.51% 40.10%
0.42% 0.27% 0.27% 0.49% 0.93% 0.25% 0.05% 0.22% 0.07% 0.13% 0.05% 0.12%
58.26% 59.68% 60.02% 62.20% 61.47% 61.68% 62.36% 62.27% 62.43% 62.36% 62.44% 59.79%
No. of Shareholders 20,30920,98124,45630,26932,24638,99641,96141,19840,31738,78638,94737,671

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls